These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34945495)

  • 1.
    Li H; Xie X; Li Y; Chen M; Xue L; Wang J; Zhang J; Wu S; Ye Q; Zhang S; Yang R; Zhao H; Wu L; Liang T; Ding Y; Wu Q
    Foods; 2021 Nov; 10(12):. PubMed ID: 34945495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cathelicidin LL-37 exerts amelioration effects against EHEC O157:H7 infection regarding inflammation, enteric dysbacteriosis, and impairment of gut barrier function.
    Fang X; Nong K; Wang Z; Jin Y; Gao F; Zeng Q; Wang X; Zhang H
    Peptides; 2023 Jan; 159():170903. PubMed ID: 36370932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota.
    Bao CL; Liu SZ; Shang ZD; Liu YJ; Wang J; Zhang WX; Dong B; Cao YH
    J Appl Microbiol; 2021 Jul; 131(1):470-484. PubMed ID: 33289241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathelicidin- derived PR39 protects enterohemorrhagic Escherichia coli O157:H7 challenged mice by improving epithelial function and balancing the microbiota in the intestine.
    Haiwen Z; Rui H; Bingxi Z; Qingfeng G; Beibei W; Jifeng Z; Xuemei W; Kebang W
    Sci Rep; 2019 Jul; 9(1):9456. PubMed ID: 31263234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathelicidin-WA Improves Intestinal Epithelial Barrier Function and Enhances Host Defense against Enterohemorrhagic Escherichia coli O157:H7 Infection.
    Yi H; Hu W; Chen S; Lu Z; Wang Y
    J Immunol; 2017 Feb; 198(4):1696-1705. PubMed ID: 28062699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Administration of Bovine Lactoferrin-Derived Lactoferricin (Lfcin) B Could Attenuate Enterohemorrhagic Escherichia coli O157:H7 Induced Intestinal Disease through Improving Intestinal Barrier Function and Microbiota.
    Haiwen Z; Rui H; Bingxi Z; Qingfeng G; Jifeng Z; Xuemei W; Beibei W
    J Agric Food Chem; 2019 Apr; 67(14):3932-3945. PubMed ID: 30892034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium Sensing Regulates Intestinal Colonization of Enterohemorrhagic Escherichia coli O157:H7.
    Liu Y; Han R; Wang J; Yang P; Wang F; Yang B
    mBio; 2020 Nov; 11(6):. PubMed ID: 33173003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterohemorrhagic Escherichia coli infection has donor-dependent effect on human gut microbiota and may be antagonized by probiotic yeast during interaction with Peyer's patches.
    Thévenot J; Cordonnier C; Rougeron A; Le Goff O; Nguyen HT; Denis S; Alric M; Livrelli V; Blanquet-Diot S
    Appl Microbiol Biotechnol; 2015 Nov; 99(21):9097-110. PubMed ID: 26084888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Cecropin-LL37 Hybrid Peptide Protects Mice Against EHEC Infection-Mediated Changes in Gut Microbiota, Intestinal Inflammation, and Impairment of Mucosal Barrier Functions.
    Wei X; Zhang L; Zhang R; Koci M; Si D; Ahmad B; Cheng J; Wang J; Aihemaiti M; Zhang M
    Front Immunol; 2020; 11():1361. PubMed ID: 32695115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
    Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization with novel EspA-Tir-M fusion protein induces protective immunity against enterohemorrhagic Escherichia coli O157:H7 challenge in mice.
    Lin R; Zhu B; Zhang Y; Bai Y; Zhi F; Long B; Li Y; Wu Y; Wu X; Fan H
    Microb Pathog; 2017 Apr; 105():19-24. PubMed ID: 28163157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New strain of
    Jiang XW; Li YT; Ye JZ; Lv LX; Yang LY; Bian XY; Wu WR; Wu JJ; Shi D; Wang Q; Fang DQ; Wang KC; Wang QQ; Lu YM; Xie JJ; Li LJ
    World J Gastroenterol; 2020 Oct; 26(40):6224-6240. PubMed ID: 33177795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antagonistic interaction between Clostridium butyricum and enterohemorrhagic Escherichia coli O157:H7].
    Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Sakazaki R; Kamiya S
    Kansenshogaku Zasshi; 1999 Jan; 73(1):7-14. PubMed ID: 10077896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterohemorrhagic Escherichia coli specific enterohemolysin induced IL-1β in human macrophages and EHEC-induced IL-1β required activation of NLRP3 inflammasome.
    Zhang X; Cheng Y; Xiong Y; Ye C; Zheng H; Sun H; Zhao H; Ren Z; Xu J
    PLoS One; 2012; 7(11):e50288. PubMed ID: 23209696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli O157:H7: animal reservoir and sources of human infection.
    Ferens WA; Hovde CJ
    Foodborne Pathog Dis; 2011 Apr; 8(4):465-87. PubMed ID: 21117940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From In silico Protein Epitope Density Prediction to Testing Escherichia coli O157:H7 Vaccine Candidates in a Murine Model of Colonization.
    Tapia D; Ross BN; Kalita A; Kalita M; Hatcher CL; Muruato LA; Torres AG
    Front Cell Infect Microbiol; 2016; 6():94. PubMed ID: 27625996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Gold Nanoparticle Vaccine against Enterohemorrhagic Escherichia coli O157:H7.
    Sanchez-Villamil JI; Tapia D; Torres AG
    mBio; 2019 Aug; 10(4):. PubMed ID: 31409688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactic acid bacteria biofilms and their ability to mitigate Escherichia coli O157:H7 surface colonization.
    Cisneros L; Cattelan N; Villalba MI; Rodriguez C; Serra DO; Yantorno O; Fadda S
    Lett Appl Microbiol; 2021 Aug; 73(2):247-256. PubMed ID: 34008189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactobacillus casei LC2W can inhibit the colonization of Escherichia coli O157:H7 in vivo and reduce the severity of colitis.
    Wang G; Zhang Y; Song X; Xia Y; Lai PF; Ai L
    Food Funct; 2019 Sep; 10(9):5843-5852. PubMed ID: 31464316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of pregnant dams with intimin(O157) protects suckling piglets from Escherichia coli O157:H7 infection.
    Dean-Nystrom EA; Gansheroff LJ; Mills M; Moon HW; O'Brien AD
    Infect Immun; 2002 May; 70(5):2414-8. PubMed ID: 11953378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.